Filter
1513
Filtered Results: 1513
Text search:
pharmaceutical
policies
Featured
Recommendations
136
New Publications
439
Language
Document type
No document type
806
Studies & Reports
311
Guidelines
201
Strategic & Response Plan
79
Manuals
63
Training Material
16
Situation Updates
13
Fact sheets
13
Resource Platforms
6
Brochures
3
Infographics
2
Countries / Regions
Kenya
67
Global
62
Ethiopia
60
India
51
South Africa
38
Nigeria
36
Western and Central Europe
36
Uganda
33
Sierra Leone
26
Nepal
25
Liberia
25
Malawi
24
Namibia
23
Ghana
22
Tanzania
22
Bangladesh
22
Zambia
22
Ukraine
20
Africa
20
Rwanda
19
Cambodia
16
Lesotho
15
Latin America and the Carribbean
15
South–East Asia Region
15
Eastern Europe
15
Indonesia
14
Syria
13
Zimbabwe
13
Philippines
13
West and Central Africa
11
Myanmar / Burma
11
East and Southern Africa
10
Botswana
9
Congo, Democratic Republic of
7
Middle East and North Africa
7
Eastern Europe and Central Asia
7
Eswatini/ Swaziland
7
Cameroon
6
Senegal
6
Asia
6
Thailand
5
Haiti
5
Germany
5
Pakistan
5
Albania
4
Burkina Faso
4
Mozambique
4
Venezuela
4
Western Pacific Region
4
South Sudan
4
Benin
3
Laos
3
Afghanistan
3
Peru
3
Guinea
3
USA
3
Vietnam
3
Brazil
3
China
2
Fiji
2
Lithuania
2
Jordan
2
North America
2
Lebanon
2
Egypt
2
Sudan
2
Mali
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
El Salvador
1
Chile
1
Iran
1
Kyrgyzstan
1
Niger
1
Mongolia
1
Bulgaria
1
Ireland
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Maldives
1
United Kingdom
1
Southern Africa
1
Argentina
1
Papua New Guinea
1
Sri Lanka
1
Yemen
1
Romania
1
Palestine
1
Central African Republic
1
Angola
1
Chad
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
655
Public Health
89
Clinical Guidelines
84
Key Resources
58
Women & Child Health
39
Pharmacy & Technologies
20
Capacity Building
10
Toolboxes
AMR
165
COVID-19
115
Pharmacy
107
Mental Health
82
TB
82
HIV
71
Rapid Response
46
Planetary Health
45
NCDs
38
Global Health Education
32
Caregiver
27
NTDs
25
Conflict
25
Health Financing Toolbox
24
Ebola
13
Refugee
10
Disability
8
Specific Hazards
7
Natural Hazards
7
Polio
6
Zika
3
Social Ethics
2
Health Financing
2
Cholera
1
The thirty-seventh meeting of the Programme, Budget and Administration Committee was held in Geneva from 25 to 27 January 2023 and chaired by Ms Aishath Rishmee (Maldives). The Committee adopted its agenda and agreed its programme of work. In his opening remarks, the Director-General emphasized the ...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
This article analyzes the impact of the COVID-19 pandemic on foreign aid. Using examples from Canadian foreign aid, it argues that, despite the terrible toll it is exacting, the crisis has accelerated some significant positive pre-existing trends, both by destabilizing the perception of aid as flowi...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
In 2006, the Special Session of African Union Health Ministers adopted the Maputo Plan of Action for implementing the Continental Policy Framework on sexual and reproductive health and rights (SRHR), which expired at the end of 2015. The goal was for all stakeholders and partners to join forces and ...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
This paper explores the angles and opportunities of digital health, with a look
at digital innovation and its potential to support patients with circulatory diseases.
In reviewing developments in the field, current applications as well as gaps, the paper aims to support policymakers in leveraging ...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt...
The Infection Prevention and Control (IPC) Guidelines aim to support healthcare workers improve quality and safety health care. The Guidelines further aim to promote and facilitate the overall goal of IPC by providing evidence-based recommendations on the critical aspects of IPC, focusing on the fun...
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, genera...
Since the discovery of insulin nearly 100 years ago, advances in diabetes treatments and therapies have transformed the lives of people
with diabetes (PwD), notably reducing the daily burden of its management.
Newer technologies, including those driven by artificial intelligence, have the potentia...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
